Research shows that metformin, the current leading type 2 diabetes medication, has the potential to improve insulin sensitivity, curb osteoarthritis development, and reduce the risk of total joint replacements.
Research shows that metformin, the current leading type 2 diabetes medication, has the potential to improve insulin sensitivity, curb osteoarthritis development, and reduce the risk of total joint replacements.
Interesting